Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease

Prenatal Diagnosis

Volumn 32, Issue 6, 2012, Pages 542-549

  Bunce, Kimberly ^a,b   Chu, Tianjiao ^a,b   Surti, Urvashi ^a,b   Hogge, William Allen ^a,b   Peters, David G ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE;

ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ANALYSIS; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; FEMALE; FETUS; FETUS DISEASE; GENE AMPLIFICATION; GENOME ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MATERNAL BLOOD; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; X CHROMOSOME;

CHORIONIC VILLI SAMPLING; CHROMOSOMES, HUMAN, PAIR 13; DINUCLEOSIDE PHOSPHATES; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL DISEASES; GENETIC MARKERS; GESTATIONAL AGE; HUMANS; MICROARRAY ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84861480685     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3853     Document Type: Article

References (39)

1. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687-94.
2. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 1986;27:1-7.
3. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1:1287-93.
4. Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. 2008. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 1986;111:589-95.
5. Hewison J, Nixon J, Fountain J, Hawkins K, Jones CR, Mason G, Morley S, Thornton JG. A randomised trial of two methods of issuing prenatal test results: the ARIA (amniocentesis results: investigation of anxiety) trial. BJOG 2007;114:462-8.
6. Hewison J, Nixon J, Fountain J, Cocks K, Jones C, Mason G, Morley S, Thornton J. Amniocentesis results: investigation of anxiety. The ARIA trial. Health Technol Assess 2006;10: iii, ix-x, 1-78.
7. Hertling-Schaal E, Perrotin F, De Poncheville L, Lansac J, Body G. [Maternal anxiety induced by prenatal diagnostic techniques: detection and management]. Gynecol Obstet Fertil 2001;29:440-6.
8. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
9. Chiu RW, Chan CW, Zhong XY, Lapaire O, Holzgreve W, Hahn S, Lo YM. Fetal rhesus D mRNA is not detectable in maternal plasma. Clin Chem 2005;51:2210-1.
10. Lo YM. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem 2000;46:1903-6.
11. Lo YM. Fetal RhD genotyping from maternal plasma. Ann Med 1999;31:308-12.
12. Li Y, Holzgreve W, Din E, Vitucci A, Hahn S. Cell-free DNA in maternal plasma: is it all a question of size? Ann N Y Acad Sci 2006;1075:81-7.
13. Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007;27:11-7.
14. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843-9.
15. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356:1170.
16. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266-71.
17. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, Zee BC, Lau TK, Cantor CR, Lo YM. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-63.
18. Chu T, Bunce K, Hogge WA, Peters DG. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease. Bioinformatics 2009a;25:1244-50.
19. Tong YK, Chiu RW, Akolekar R, Leung TY, Lau TK, Nicolaides KH, Lo YM. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One 2010;5:e15244.
20. Hasselmann DO, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001;47:1488-9.
21. Gupta AK, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem 2004;50:2187-90.
22. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-8.
23. Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YM. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 2006;52:2194-202.
24. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-23.
25. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, Carter NP, Patsalis PC. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009;174:1609-18.
26. Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 2009b;29:1020-30.
27. Old RW, Crea F, Puszyk W, Hulten MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007;15:227-35.
28. Della Ragione F, Mastrovito P, Campanile C, Conti A, Papageorgiou EA, Hulten MA, Patsalis PC, Carter NP, D'Esposito M. Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies. J Mol Diagn 2010;12:797-807.
29. Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, Yu L, Lau TK, Lo YM. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2009;56:90-8.
30. Brown L, Brown G, Vacek P, Brown S. Aneuploidy detection in mixed DNA samples by methylation-sensitive amplification and microarray analysis. Clin Chem 2010;56:805-13.
31. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011;17:510-3.
32. Tsui DW, Chiu RW, Lo YD. Epigenetic approaches for the detection of fetal DNA in maternal plasma. Chimerism 2011;1:30-5.
33. Iovannisci DM, Ha TT, Shaw GM. Recovery of genomic DNA from residual frozen archival blood clots suitable for amplification and use in genotyping assays. Genet Test 2006;10:44-9.
34. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Bio 2004;3: Article 3.
35. Tsui NB, Akolekar R, Chiu RW, Chow KC, Leung TY, Lau TK, Nicolaides KH, Lo YM. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 2009;56:73-81.
36. Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M, Jacobsen SE. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008;452:215-9.
37. Tsui DW, Lam YM, Lee WS, Leung TY, Lau TK, Lau ET, Tang MH, Akolekar R, Nicolaides KH, Chiu RW, Lo YM, Chim SS. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome. PLoS One 2010;5:e15069.
38. Lo YM. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG 2009;116:152-7.
39. Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, Jin Y, Yang N, Tong YK, Leung TY, Lau TK, Ding C, Chiu RW, Lo YM. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008;54:500-11.